Announcements Trials

Browse Landscape

Phase

Phase NA 1 Phase 4 1 Phase 3 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 148 Breast Neoplasms 117 Prostatic Neoplasms 62 Multiple Myeloma 57 Neoplasms 56 Lung Neoplasms 50 Neoplasm Metastasis 44 Parkinson Disease 4, Autosomal Dominant Lewy Body 36 Ovarian Neoplasms 36 Colorectal Neoplasms 35 Leukemia, Lymphocytic, Chronic, B-Cell 33 Carcinoma, Renal Cell 27 Recurrence 26 Leukemia, Myeloid, Acute 26 Urinary Bladder Neoplasms 25 Carcinoma, Hepatocellular 24 Small Cell Lung Carcinoma 23 Myasthenia Gravis 22 Triple Negative Breast Neoplasms 21 Endometrial Neoplasms 21 Squamous Cell Carcinoma of Head and Neck 20 Lymphoma, Large B-Cell, Diffuse 20 Lymphoma, Follicular 20 Melanoma 19 Nasopharyngeal Carcinoma 18 Fallopian Tube Neoplasms 18 Stomach Neoplasms 17 Non-Muscle Invasive Bladder Neoplasms 16 Brain Neoplasms 16 Pancreatic Neoplasms 15

Interventions

ledipasvir, sofosbuvir drug combination 1 ledipasvir 1 daclatasvir 1 Sofosbuvir 1 Simeprevir 1 Ribavirin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 3 × Hepatitis C, Chronic × 90 days × Clear all

NCT02771405 2026-04-13

FRI-STC

National Hepatology & Tropical Medicine Research Institute

Phase 3 Completed

Gastrointestinal

Carcinoma, Hepatocellular, Hepatitis C, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon ⚡